Get the Stockscreener App
14.13
0.36%
0.05
Pre-market:
14.48
0.35
+2.48%
Clearpoint Neuro Inc stock is traded at $14.13, with a volume of 389.18K.
It is up +0.36% in the last 24 hours and down -19.35% over the past month.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
See More
Previous Close:
$14.08
Open:
$13.7
24h Volume:
389.18K
Relative Volume:
0.38
Market Cap:
$420.34M
Revenue:
$30.43M
Net Income/Loss:
$-18.15M
P/E Ratio:
-20.48
EPS:
-0.69
Net Cash Flow:
$-9.08M
1W Performance:
-2.15%
1M Performance:
-19.35%
6M Performance:
+8.78%
1Y Performance:
+11.08%
1-Day Range:
$13.60
$14.19
1-Week Range:
$13.00
$14.59
52-Week Range:
$9.76
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
14.13 | 418.86M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Oct-24-23 | Initiated | Stifel | Buy |
| Feb-16-23 | Resumed | B. Riley Securities | Buy |
| Apr-05-22 | Resumed | B. Riley Securities | Buy |
| Mar-18-21 | Initiated | Lake Street | Buy |
| Jul-17-20 | Initiated | B. Riley FBR | Buy |
View All
Clearpoint Neuro Inc Stock (CLPT) Latest News
Can ClearPoint Neuro Inc. stock withstand economic slowdownMarket Sentiment Review & Free Safe Entry Trade Signal Reports - Newser
Is ClearPoint Neuro Inc. stock positioned well for digital economyPortfolio Risk Summary & Daily Entry Point Alerts - Newser
ClearPoint Neuro (CLPT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will ClearPoint Neuro Inc. stock maintain dividend yieldJuly 2025 Macro Moves & Free Daily Entry Point Trade Alerts - Newser
CLPT SEC FilingsClearpoint Neuro Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT) and Bristol-Myers Squibb (BMY) - The Globe and Mail
[Form 4] ClearPoint Neuro, Inc. Insider Trading Activity - Stock Titan
What analysts say about ClearPoint Neuro Inc stockGlobal Trade Effects & Superior Growth Investment - earlytimes.in
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and ClearPoint Neuro (CLPT) - The Globe and Mail
What drives ClearPoint Neuro Inc stock priceMarket Sentiment Report & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
ClearPoint Neuro Completes Acquisition of IRRAS Holdings - MSN
ClearPoint Neuro completes acquisition of IRRAS Holdings By Investing.com - Investing.com India
ClearPoint Neuro completes acquisition of IRRAS Holdings - Investing.com
How (CLPT) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
[8-K] ClearPoint Neuro, Inc. Reports Material Event | CLPT SEC FilingForm 8-K - Stock Titan
ClearPoint Neuro Completes Acquisition of IRRAS - ACCESS Newswire
ClearPoint (Nasdaq: CLPT) closes IRRAS deal, adding IRRAflow and 50+ customers - Stock Titan
Is ClearPoint Neuro Inc. stock a top pick in earnings seasonShare Buyback & Real-Time Volume Spike Alerts - newser.com
Will ClearPoint Neuro Inc. stock attract more institutional investorsJuly 2025 Trends & Safe Capital Growth Tips - newser.com
ClearPoint Neuro, Inc. completed the acquisition of Irras Holdings Inc. - MarketScreener
How ClearPoint Neuro Inc. stock performs during Fed tightening cycles2025 Top Decliners & Short-Term Swing Trade Alerts - newser.com
Using economic indicators to assess ClearPoint Neuro Inc. potential2025 Market Trends & Safe Swing Trade Setups - newser.com
Will ClearPoint Neuro Inc. stock deliver long term returns - newser.com
CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.0 - MSN
What margin trends mean for ClearPoint Neuro Inc. stockPortfolio Gains Report & Safe Entry Zone Identification - newser.com
What risks investors should watch in ClearPoint Neuro Inc. stockPortfolio Update Summary & AI Forecast for Swing Trade Picks - newser.com
Why ClearPoint Neuro Inc. stock could be next big winnerInsider Selling & Weekly Chart Analysis and Guides - newser.com
How resilient is ClearPoint Neuro Inc. stock in market downturnsJuly 2025 News Drivers & Real-Time Buy Signal Alerts - newser.com
ClearPoint Neuro’s Strategic Growth Highlighted in Earnings Call - MSN
Will ClearPoint Neuro Inc. stock outperform growth indexes2025 Macro Impact & Community Consensus Stock Picks - Fundação Cultural do Pará
Earnings call transcript: ClearPoint Neuro Q3 2025 misses revenue forecast By Investing.com - Investing.com South Africa
Earnings call transcript: ClearPoint Neuro Q3 2025 misses revenue forecast - Investing.com India
Despite currently being unprofitable, ClearPoint Neuro (NASDAQ:CLPT) has delivered a 66% return to shareholders over 5 years - Yahoo Finance
Can ClearPoint Neuro Inc. stock hit record highs again2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com
Long term hold vs stop loss in ClearPoint Neuro Inc.July 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Using portfolio simulators with ClearPoint Neuro Inc. includedJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2025 Earnings Call Transcript - Insider Monkey
ClearPoint Neuro Inc Stock Analysis and ForecastLarge Cap Stability Picks & Register for the Next Free Workshop - earlytimes.in
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.89%
4.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):